These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5593571)

  • 1. [Effect of clofibrate on serum lipids in atherosclerosis].
    Gietz E
    Med Klin; 1967 Mar; 62(9):336-8 passim. PubMed ID: 5593571
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of long term therapy with clofibrate in atherosclerosis.
    Ayad H
    J Egypt Med Assoc; 1968; 51(1):57-69. PubMed ID: 5672921
    [No Abstract]   [Full Text] [Related]  

  • 3. [Increase of fibrinolytic activity and reduction of platelet adhesiveness caused by prolonged treatment with ethyl-chloro-phenoxy-isobutyrate].
    Frandoli G; Gibelli A; Giarola P
    Clin Ter; 1966 Jul; 38(1):27-38. PubMed ID: 4230052
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of Clofibrate on blood coagulation].
    Barth P; Kommerell B
    Med Klin; 1966 Sep; 61(37):1466-8. PubMed ID: 4867653
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate].
    Barisone D; Gallo G; Accardo S
    Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766
    [No Abstract]   [Full Text] [Related]  

  • 6. [Atherosclerosis and Regelan].
    Schwaar R
    Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
    [No Abstract]   [Full Text] [Related]  

  • 7. [Arteriosclerosis with special reference to anticholesteremic agents].
    Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
    Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of ethyl alpha-p-chlorophenoxyisobutyrate (Clofibrate) on lipids, cholesterol and uric acid in diabetes mellitus].
    Orsetti A; Mirouze J
    Therapie; 1966; 21(3):685-91. PubMed ID: 5942133
    [No Abstract]   [Full Text] [Related]  

  • 9. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
    Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F
    Med Welt; 1967 Aug; 32():1848-60. PubMed ID: 5589916
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of Atromid on blood lipids in patients with hyperlipemia].
    Baranova LV
    Ter Arkh; 1968 Mar; 40(3):15-20. PubMed ID: 4875984
    [No Abstract]   [Full Text] [Related]  

  • 13. Injury, serum lipids, fat embolism, and clofibrate.
    O'Driscoll M; Powell FJ
    Br Med J; 1967 Oct; 4(5572):149-51. PubMed ID: 6053980
    [No Abstract]   [Full Text] [Related]  

  • 14. [Influence of beta-benzabutyramide on the blood lipids and on the thrombodensitogram].
    Ferri F; Regazzini A; Pedini G
    G Gerontol; 1970 Mar; 18(3):203-18. PubMed ID: 5473222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of chlorophenoxy-isobutyric ester on platelet adhesiveness and aggregation in the patients with arteriosclerosis and diabetes mellitus].
    Yasunaga K
    Naika Hokan; 1969 Oct; 16(10):393-403. PubMed ID: 5391800
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-experimental studies of the influence of Atherolip on lipid and carbohydrate metabolism].
    Hammerl H; Kränzl C; Pichler O; Studlar M
    Med Welt; 1969 Aug; 31():1715-7. PubMed ID: 4895455
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug therapy of atherosclerosis].
    Negoiţă CI
    Med Interna (Bucur); 1971 Mar; 23(3):325-33. PubMed ID: 5574929
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of ethyl-chlorphenoxy-isobutyrate on serum lipid values in coronary sclerosis].
    Keller L; Rétsági G; Sebestyén M; Diezendy S; Erdélyi G
    Orv Hetil; 1966 May; 107(22):1020-2. PubMed ID: 5935787
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations on the effect of ethyl a-p chlorophenoxyisobutyrate (CPIB) therapy on serum lipid levels and on diabetic and some other retinopathies.
    Vannas S; Esilä R; Tuovinen E
    Acta Ophthalmol (Copenh); 1968; 46(2):162-70. PubMed ID: 5755673
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prolonged use of atromid in patients with coronary arteriosclerosis].
    Zadionchenko VS
    Kardiologiia; 1967 Oct; 7(10):32-5. PubMed ID: 5607197
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.